Article thumbnail
Location of Repository

Background are increasingly being recognized, due to the availability of WORLD JOURNAL OF SURGICAL ONCOLOGY



Full list of author information is available at the end of the articleAdrenocortical carcinoma (ACC) is rare and has a poor prognosis. Even for patients with resected tumors, the median survival is only 32 months in the United States [1]. While ACC is uncommon with an annual incidence of 0.5 to 2.0 per million people, adrenal incidentalomas superior imaging techniques, with a reported prevalence of 3 % to 4 % on abdominal CT scan [1-5]. Most adrenal incidentalomas are benign, while most malignant adrenal tumors are metastatic in origin [6]. As such, accurate diag-nosis of malignant adrenocortical tumors, particularly distinguishing ACC from adrenal adenomas, is essential for management; however, accurate diagnosis continues to remain a challenge. There are continued significant areas of uncertainty regarding pathogenesis and risk as

Year: 2016
OAI identifier: oai:CiteSeerX.psu:
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.